PATEO (02889) Directors and Senior Management Make 12-Month Voluntary Lock-Up Commitment to Boost Market Confidence
PATEO (02889) announced that, in order to further demonstrate the firm confidence of the directors and senior management in the Group's long-term business development and intrinsic value, and to stabilize investor expectations, executive directors Ying Zhenkai, Zhang Fukai, Xu Zhenhui, Lai Weilin and employee director Zhang Yi have made written voluntary lock-up undertakings to the Company.
PATEO (02889) announced that, in order to further demonstrate the firm confidence of the directors and senior management in the Group's long-term business development and intrinsic value, and to stabilize investor expectations, executive directors Ying Zhenkai, Zhang Fukai, Xu Zhenhui, Lai Weilin and employee director Zhang Yi have made written voluntary lock-up undertakings to the Company.
The above persons undertook that within 12 months from the date of the announcement, they will not, by any means (including but not limited to sales in the secondary market, block trades, off-market negotiated transfers, pledges, establishment of trusts, equity swaps or derivative transactions, etc.), sell, transfer or dispose of shares beneficially owned by them or held through employee incentive platforms, or create any other encumbrance over such shares that affects their interests therein.
Among them, executive director and chairman Ying Zhenkai beneficially holds approximately 32,295,600 domestic shares and 204,640 H shares, and holds partnership interests in 7 employee incentive platforms; the other undertaking parties also directly hold shares or hold partnership interests in the relevant employee incentive platforms.
Related Articles
.png)
J&T EXPRESS-W (01519) repurchased 2.6 million shares for HK$23.9515 million on October 13.

Guotai Haitong (02611) appoints Zhang Xinjun to concurrently serve as the company's Chief Risk Officer.

SIMCERE PHARMA (02096) repurchased 1.428 million shares for HK$15.3431 million on October 13.
J&T EXPRESS-W (01519) repurchased 2.6 million shares for HK$23.9515 million on October 13.
.png)
Guotai Haitong (02611) appoints Zhang Xinjun to concurrently serve as the company's Chief Risk Officer.

SIMCERE PHARMA (02096) repurchased 1.428 million shares for HK$15.3431 million on October 13.






